SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001274644-17-000011
Filing Date
2017-03-10
Accepted
2017-03-10 08:07:51
Documents
3
Period of Report
2017-03-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K - EARNINGS RELEASE ocera-form8xkxearningsrele.htm 8-K 27421
2 EXHIBIT 99.1 exhibit991oceraearningsrel.htm EX-99.1 110640
3 oceralogoa20.jpg GRAPHIC 11170
  Complete submission text file 0001274644-17-000011.txt   154705
Mailing Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301
Business Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301 6504625800
Ocera Therapeutics, Inc. (Filer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35119 | Film No.: 17680238
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences